| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.5 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.037 | 0.5 |